Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05921123
Status:
RECRUITING
Last Update Posted:
2024-01-26
First Post:
2023-06-09
Brief Title:
Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition a Tissue Biopsy Based imaGing Study
Sponsor:
University Hospital Brest
Organization:
University Hospital Brest
Organization Data
Organization:
University Hospital Brest
Class:
OTHER
Study ID:
29BRC220219 TADIG-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Brest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None